Share Price:

APNASPENAspen Pharmacare Hldgs10017-54 (-0.54%)
Our Response to Covid
Country Sites

Day: January 30, 2023

Tragic passing of Riaan Verster (46)

Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), regrets to announce the untimely and tragic passing of Riaan Verster, Aspen Group Executive: Governance & Communications, on Saturday 28 January 2023. Riaan regrettably succumbed to his injuries sustained in a motor cycle accident.   Stephen Saad, Aspen Group Chief Executive, said, “Riaan was a dear… Continue reading Tragic passing of Riaan Verster (46)

Our Purpose

Find out more
To improve the health and quality of life of patients.

Our Vision

Find out more
To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.

Our Values

Find out more
Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.
aspen-holdings-logo-white-img

Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912

Medical Careline (South Africa) 0800 118 088

Facebook-f Twitter-square Instagram Linkedin

About Aspen

We Care

Careers

Contact Us

ASPEN PHARMACARE HOLDINGS LTD: Switchboard: +27 31 580-8600

Aspen Place, 9 Rydall Vale Park
Douglas Saunders Drive, La Lucia Ridge South Africa

P.O. Box 25125, Gateway, Kwa‑Zulu Natal, 4321, South Africa

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.